|
Ayala de la Pena F, Antolin Novoa S, Gavila Gregori J, Gonzalez Cortijo L, Henao Carrasco F, Martinez Martinez MT, Morales Estevez C, Stradella A, Vidal Losada MJ, Ciruelos E. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clin Transl Oncol. 2023 Sep;25(9):2647-2664. doi: 10.1007/s12094-023-03215-4. Epub 2023 Jun 16. Erratum In: Clin Transl Oncol. 2024 Feb;26(2):555-556. doi: 10.1007/s12094-023-03334-y. PubMed PMID: 37326826; PubMed Central PMCID: PMC10425528.
AÑO: 2023; IF: 2.8
|
37326826
|
Castillo-Guardiola V, Rosado-Jimenez L, Sarabia-Meseguer MD, Marin-Vera M, Macias-Cerrolaza JA, Garcia-Hernandez R, Zafra-Poves M, Sanchez-Henarejos P, Moreno-Locubiche MA, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet. 2022 Apr;65(4):104468. doi: 10.1016/j.ejmg.2022.104468. Epub 2022 Mar 1. PubMed PMID: 35245693.
AÑO: 2022; IF: 1.9
|
|
Navarro-Manzano E, Luengo-Gil G, Gonzalez-Conejero R, Garcia-Garre E, Garcia-Martinez E, Garcia-Torralba E, Chaves-Benito A, Vicente V, Ayala de la Pena F. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer. Cancers (Basel). 2022 May 12;14(10):2390. doi: 10.3390/cancers14102390. PubMed PMID: 35625994; PubMed Central PMCID: PMC9139340.
AÑO: 2022; IF: 6.575
|
|
Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, Garcia Garre E, Vicente V, Ayala de la Pena F. A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge. ESMO Open. 2022 Feb;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. Epub 2022 Feb 7. PubMed PMID: 35144121; PubMed Central PMCID: PMC8844687.
AÑO: 2022; IF: 6.883
|
|
Ayala de la Pena F, Ortiz-Munoz B, Quintanar-Verduguez T, Santotoribio JD, de la Cruz S, Trape-Pujol J, Galve-Calvo E, Auge-Fradera JM, Garcia-Gomez J, Gonzalez-Hernandez A. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer. Clin Transl Oncol. 2021 Jul;23(7):1272-1280. doi: 10.1007/s12094-020-02529-x. Epub 2021 Feb 7. PubMed PMID: 33550504; PubMed Central PMCID: PMC8192375.
AÑO: 2021; IF: 3.34
|